BIOLASE to Present at Upcoming Investment Conferences
08 Mayo 2012 - 8:00AM
Marketwired
BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental
laser manufacturer and distributor, today announced that management
is scheduled to make investor presentations at three upcoming
investment conferences.
The first conference will be Security Research Associates' 8th
Annual Spring Growth Stock Conference on Tuesday, May 15, during
which CFO and COO Frederick Furry is scheduled to present at 2:30
pm Pacific Time. The conference is being held at the Le Meridien
Hotel in San Francisco. A live audio webcast of the presentation at
this conference will be available in the Investors section of the
BIOLASE website at www.biolase.com.
The second conference will be the 13th Annual B. Riley & Co.
Investor Conference on Wednesday, May 23, during which CFO and COO
Frederick Furry is scheduled to present at 2:00 pm Pacific Time.
The conference is being held at the Loews Santa Monica Beach Hotel
in Santa Monica, CA.
The third conference will be SunTrust Robinson Humphrey's Annual
Veterinary and Dental Conference on Wednesday, May 30, during which
Chairman and CEO Federico Pignatelli is scheduled to host
one-on-one and small group meetings throughout the day. The
conference is being held at the Le Meridien Hotel in New York
City.
About BIOLASE Technology, Inc. BIOLASE
Technology, Inc., the World's leading Dental Laser Company, is a
medical technology company that develops, manufactures and markets
dental lasers and also distributes and markets dental imaging
equipment, products that are focused on technologies that advance
the practice of dentistry and medicine. The Company's laser
products incorporate 285 patented and patent pending technologies
designed to provide clinically superior performance with less pain
and faster recovery times. Its imaging products provide
cutting-edge technology at competitive prices to deliver the best
results for dentists and patients. BIOLASE's principal products are
dental laser systems that perform a broad range of dental
procedures, including cosmetic and complex surgical applications,
and a full line of dental imaging equipment. BIOLASE has sold more
than 19,000 lasers among 16,000 customers. Other products under
development address ophthalmology and other medical and consumer
markets.
For updates and information on laser and Waterlase dentistry,
find BIOLASE at http://www.biolase.com, Twitter at
http://twitter.com/GoWaterlase, and YouTube at
http://www.youtube.com/user/Rossca08.
This press release may contain forward-looking statements within
the meaning of safe harbor provided by the Securities Reform Act of
1995 that are based on the current expectations and estimates by
BIOLASE management. These forward-looking statements can be
identified through the use of words such as "anticipates,"
"expects," "intends," "plans," "believes," "seeks," "estimates,"
"may," "will," and variations of these words or similar
expressions. Forward-looking statements are based on management's
current, preliminary expectations and are subject to risks,
uncertainties and other factors which may cause the Company's
actual results to differ materially from the statements contained
herein, and are described in the Company's reports it files with
the Securities and Exchange Commission, including its annual and
quarterly reports. No undue reliance should be placed on
forward-looking statements. Such information is subject to change,
and BIOLASE undertakes no obligation to update such statements.
For further information, please contact: Jill Bertotti Allen
& Caron +1-949-474-4300 jill@allencaron.com
Biolase (NASDAQ:BLTI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Biolase (NASDAQ:BLTI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024